Saint Louis University.
Oncology Nursing Society in Pittsburgh, PA.
Clin J Oncol Nurs. 2020 Aug 1;24(4):430-433. doi: 10.1188/20.CJON.430-433.
Cancer-related hot flashes are often a lasting and distressing side effect of hormone-blocking therapies that are most often experienced by women with breast cancer and men with prostate cancer treated with these therapies. Hot flashes have been defined as a sensation of heat that may be accompanied by facial flushing, perspiration, chills, heart palpitations, night sweats, and feelings of anxiety. The frequency and intensity of hot flashes can cause fatigue and sleep disturbances that diminish quality of life and reduce adherence with prescribed therapies that block estrogens or androgens. Hot flashes are reported to be significantly more frequent and severe in women treated for breast cancer than in women undergoing natural menopause. They also commonly occur in men treated for prostate cancer with surgical or chemical castration to block the synthesis of androgens that can fuel cancer growth.
癌症相关性热潮红通常是激素阻断疗法的一种持久且令人痛苦的副作用,这种副作用最常发生在接受这些疗法治疗的乳腺癌女性和前列腺癌男性中。热潮红被定义为一种发热的感觉,可能伴有面部潮红、出汗、寒战、心悸、盗汗和焦虑感。热潮红的频率和强度会导致疲劳和睡眠障碍,从而降低生活质量,并降低服用雌激素或雄激素阻断剂的依从性。与自然绝经的女性相比,接受乳腺癌治疗的女性报告热潮红更为频繁和严重。在接受手术或化学去势以阻断促进癌症生长的雄激素合成的前列腺癌男性中,热潮红也很常见。